Viatris Inc.

VTRS Healthcare Drug Manufacturers Specialty & Generic

Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.88%, EPS fell 2,464.1%, free cash flow grew 101.1% and total debt fell 18.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years.

18.66 0.44 +2.41%
Market cap
$20.9B
P/E
0.0×
Fwd P/E
61.1×
Dividend yield
2.57%
F-score
4/9
Altman Z
0.61
Beneish M
−3.29
Dividend safety
37/100

Viatris Inc. (VTRS) Book value per share

Alert me on Book value per share

Viatris Inc.'s book value per share at the end of fiscal 2025 was 12.6×, down 19.5% from 15.6× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 12.3×. Over the past ten years it has ranged from 12.6× (fiscal 2025) to 38.2× (fiscal 2020) — the current reading is the lowest in ten years. Viatris Inc. ranks 16th of 86 Drug Manufacturers Specialty & Generic companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 12.6× (19.53%)
FY2024 15.6× (8.42%)
FY2023 17.1× (1.92%)
FY2022 17.4× 2.55%
FY2021 17.0× (55.60%)
FY2020 38.2× 65.69%
FY2019 23.0× (2.56%)
FY2018 23.6× (5.02%)
FY2017 24.9× 14.88%
FY2016 21.7× 4.79%

Quarterly newest first

Period Book value per share Change
Jun 2026 12.3× (3.37%)
Mar 2026 12.7× 0.96%
Dec 2025 12.6× (3.83%)
Sep 2025 13.1× (1.56%)
42 more quarters

Against its own ten years

Low 12.6× High 38.2×
Ten-year median 20.7×
Current reading's percentile 9

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on VTRS